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Introduction {#jdi13025-sec-0005}
============

Diabetes mellitus is one of the most prevalent chronic diseases worldwide. It was estimated that there were 425 million people with diabetes mellitus aged 20--79 years and the global proportion of undiagnosed diabetes mellitus was 49.7% among diabetes patients in 2017[1](#jdi13025-bib-0001){ref-type="ref"}. Furthermore, the number of people with diabetes mellitus aged 20--79 years would be predicted to increase to 629 million by 2045[1](#jdi13025-bib-0001){ref-type="ref"}. Also in Japan, it was estimated that there were 7.23 million adults with diabetes mellitus, while 46.6% of those (3.36 million adults) were undiagnosed diabetes mellitus[2](#jdi13025-bib-0002){ref-type="ref"}.

For secondary prevention, early detection of pre‐symptomatic people and the implementation of health guidance, as well as the initiation of physician visits, are important. Therefore, the Japanese government implemented a "specific health checkup and health guidance" in the fiscal year (FY) 2008 for the early detection of metabolic syndrome among middle‐aged people through specific health checkups, and to reduce the number of people at a high risk for lifestyle‐related diseases by risk‐stratified health guidance. Furthermore, Japanese insurers have recently implemented "data health plans" for the secondary prevention of lifestyle diseases using linked specific health checkup and claims data.

In addition to encouraging the initiation of physician visits, it is important to monitor physician visit patterns and clarify whether patients receive regular/continuous treatment using claims data. Indeed, a recent study in Japan using health examination and claims data of health insurance societies reported that untreated patients had worse glycemic control, and the number of clinic visits was dose‐dependently associated with better glycated hemoglobin (HbA1c) levels than those with no diabetes management, in a population of newly screened individuals with diabetes[3](#jdi13025-bib-0003){ref-type="ref"}. However, as the proportion of people receiving continuous diabetic treatment in Japan is still low, it is important not only to initiate physician visits, but also to provide continuous treatment.

In contrast, in terms of access to care, it is important to consider the effect of socioeconomic status, such as income and levels of education, on care continuity. A study carried out in Canada reported that having higher levels of education was positively associated with the number of general practitioner visits, and Canadians with higher incomes and education levels were more likely to visit a specialist at least once a year[4](#jdi13025-bib-0004){ref-type="ref"}. Brown *et al*.[5](#jdi13025-bib-0005){ref-type="ref"} showed that socioeconomic position affects health outcomes through access to healthcare, such as primary care‐provider visits, specialty visits and waiting times. Although several previous studies have shown the association between socioeconomic status and untreated diabetes mellitus or discontinued treatment, few studies have focused on the effects on glycemic control as a result of physician visit patterns[6](#jdi13025-bib-0006){ref-type="ref"}, [7](#jdi13025-bib-0007){ref-type="ref"}, [8](#jdi13025-bib-0008){ref-type="ref"}.

Therefore, the purpose of the present study was to evaluate the effects of income levels on physician visit patterns, and to quantify the impact of irregular physician visits on glycemic control among health insurance beneficiaries.

Methods {#jdi13025-sec-0006}
=======

Data Sources {#jdi13025-sec-0007}
------------

We obtained data on untreated diabetes patients from specific health checkup data of the Fukuoka branch of the Japanese Health Insurance Association, which insured employees among small and medium enterprises. Figure [1](#jdi13025-fig-0001){ref-type="fig"} shows the inclusion and exclusion criteria, and the participant selection flow chart. Of the 1,899,563 eligible insurance beneficiaries at the end of [FY2013](FY2013), we extracted 441,832 of those who attended health checkups between [FY2011](FY2011) and [FY2013](FY2013). As the Japan Diabetes Society unit for HbA1c was used in specific health checkups until [FY2011](FY2011), we converted the HbA1c (Japan Diabetes Society) value measured in [FY2011](FY2011) to a National Glycohemoglobin Standardization Program unit[9](#jdi13025-bib-0009){ref-type="ref"}. Then, we identified 9,119 insurance beneficiaries whose HbA1c (National Glycohemoglobin Standardization Program) values were \>6.5% and those without antihyperglycemic treatment. Furthermore, we excluded those in whom the HbA1c level was not measured in the health checkup after 2 years and those already receiving regular treatment for diabetes mellitus, as shown in Figure [2](#jdi13025-fig-0002){ref-type="fig"}. Those aged \<40 years or \>64 years, residents of other prefectures and those whose responses to questionnaires were not available at the baseline were also excluded. Finally, we excluded those admitted to the hospital, those who received hemodialysis or peritoneal dialysis before the baseline and those in whom insulin treatment was initiated after the baseline health checkup. Finally, 2,981 insurance beneficiaries were selected as the study participants.

![Flowchart of inclusion and exclusion criteria. HbA1c, glycated hemoglobin](JDI-10-1372-g001){#jdi13025-fig-0001}

![Example of categorization by physician visit patterns.](JDI-10-1372-g002){#jdi13025-fig-0002}

Study Variables {#jdi13025-sec-0008}
---------------

As the American Diabetes Association recommends the measurement of HbA1c levels every 3 months and the expiry time of prescriptions is 3 months in the Japanese health insurance system, we defined cases in which the physician was not visited for diabetes mellitus for \>3 months as "irregular visits" during the 1 year after the health checkup, as shown in Figure [2](#jdi13025-fig-0002){ref-type="fig"}, [10](#jdi13025-bib-0010){ref-type="ref"}. Thus, we assigned 650 patients to the regular visit group and 2,331 to the irregular visit group.

Ethical Consideration {#jdi13025-sec-0009}
---------------------

The need for informed consent was waived according to the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan, because the study was a retrospective cohort and the data analyzed were anonymized[11](#jdi13025-bib-0011){ref-type="ref"}. This study was approved by the Kyushu University Institutional Review Board for Clinical Research (No. 28‐84).

Outcome Measurements {#jdi13025-sec-0010}
--------------------

Following the definition of poor glycemic control in a previous study[3](#jdi13025-bib-0003){ref-type="ref"}, we defined participants whose HbA1c values were \>7.0% at the health checkup after 2 years of follow up as having poor glycemic control. An absolute increase in the HbA1c level \>0.5% was defined as one outcome variable, because the baseline HbA1c value~~s~~ were \>6.5% among all participants. Other outcomes were an absolute increase \>1.0% and a relative increase \>20% in relation to the baseline HbA1c value.

Definition of Covariates {#jdi13025-sec-0011}
------------------------

Ages were categorized into five groups: 40--44 years, 45--49 years, 50--54 years, 55--59 years and 60--64 years. Participants with a body mass index \>25.0 kg/m^2^ were defined as overweight. HbA1c values at the baseline were categorized into three groups: 6.5--6.9%, 7.0--9.9% and ≥10.0%. According to the cut‐off values of liver enzymes for recommendation to detailed examinations in specific health checkups, those with an alanine aminotransferase level \>50 U/L, aspartate aminotransferase level \>50 U/L or gamma‐glutamyltransferase level \>100 U/L were defined as having abnormal liver function. According to laboratory values and replies to questions about medications, comorbidities such as hypertension and hypercholesterolemia were categorized into three groups: normal, without medication and with medication. Participants with systolic blood pressure \<140 mmHg and diastolic blood pressure \<90 mmHg were defined as normotensive. Those not using antihypertensive drugs and whose systolic blood pressure values were \>140 mmHg or diastolic blood pressure was \>90 mmHg were defined as having untreated hypertension; the remaining patients were defined as having hypertension with medication. Similarly, according to the cut‐off values for triglycerides (150 mg/dL) and low‐density lipoprotein cholesterol (90 mg/dL), participants were categorized into three groups: (i) without hypercholesterolemia; (ii) with untreated hypercholesterolemia; and (iii) hypercholesterolemia with medication. Using claims data after the baseline health checkup, we collected information on oral antidiabetic agent prescriptions. Those who had smoked over the past month and had smoked a total of \>100 cigarettes or who had smoked over a period of 6 months were defined as smokers. Those who had habitually exercised for \>30 min twice a week for at least 1 year or who habitually walked for \>1 h a day were defined as engaging in physical activity. Alcohol consumption was categorized into five groups: (i) rarely or never; (ii) occasionally; (iii) drank \<19 g every day; (iv) drank 20--39 g every day; and (v) drank \>40 g every day in ethanol converted units. Walking faster, eating before sleeping, eating fast and sleeping well were used as explanatory variables. Based on questions on lifestyle improvement, we categorized participants into four groups: (i) not planning; (ii) starting in the future; (iii) starting soon; and (iv) already trying. Based on standard monthly incomes, which is the calculation basis for insurance premiums, we categorized them into five groups: (i) ≤\$1,999; (ii) \$2,000--2,999; (iii) \$3,000--3,999; (iv) \$4,000--4,999; and (v) ≥\$5,000 (US\$1 = ¥100). Additionally, the number of dependents was used as a proxy variable of family composition and was categorized into 0, one, two or more.

Statistical Analysis {#jdi13025-sec-0012}
--------------------

As the study\'s participants were attendees of specific health checkups, the presence of selection bias could not be ruled out. Furthermore, the estimates would be distorted by regression toward the mean. Therefore, we implemented 1:1 propensity score matching to select an adequate control group, and to show the cause--effect relationship between socioeconomic status and the deterioration of glycemic control through irregular physician visits[12](#jdi13025-bib-0012){ref-type="ref"}. In accordance with previous studies of variable selection with propensity score matching[13](#jdi13025-bib-0013){ref-type="ref"}, [14](#jdi13025-bib-0014){ref-type="ref"}, [15](#jdi13025-bib-0015){ref-type="ref"}, we calculated propensity scores using a logistic regression model to identify the relationships between irregular physician visits and the covariates defined above. Furthermore, we introduced dummy variables for 13 residential secondary medical tiers in Fukuoka (i.e., 12 variables). We used the Hosmer--Lemeshow test and C‐statistic as indicators of how well the logistic regression model fitted the data. Finally, each participant in the regular visit group was matched with a unique control in the irregular visit group within a caliper width of 0.02[16](#jdi13025-bib-0016){ref-type="ref"}.

Risk Estimation {#jdi13025-sec-0013}
---------------

Multiple logistic regression analyses were used to estimate the effects of irregular visits on outcomes after adjusting for sex, age, overweight, baseline HbA1c level, oral hypoglycemic agent use, other lifestyle diseases and lifestyle habits. Odds ratios (ORs) and their 95% confidence intervals (CIs) were computed to quantify these effects. All statistical analyses used Stata for Windows, version 15.1 (StataCorp, College Station, TX, USA). The level of statistical significance was set at 0.05.

Results {#jdi13025-sec-0014}
=======

Descriptive Statistics {#jdi13025-sec-0015}
----------------------

The descriptive statistics of the participants before propensity score matching are shown on the left in Table [1](#jdi13025-tbl-0001){ref-type="table"}. The proportion of elderly people was lower in the irregular visit group than the regular visit group, and this difference was statistically significant. The proportion of those with an HbA1c level \<7.0 (relatively mild cases) was higher in the irregular visit group. Among those with hypertension or hypercholesterolemia, the proportion of those with medication was higher in the regular visit group, whereas that of those without was higher in the irregular visit group. The number of smokers or participants who skipped breakfast tended to be higher in the irregular visit group. There were significant differences in the proportions of lifestyle improvements between the two groups, whereas the proportion of those who were already trying was higher in the regular visit group.

###### 

Baseline characteristics of participants by physician visit patterns and their effects on irregular physician visits

                                                   Physician visit pattern   Absolute standardized difference   *P*‐value   Propensity score estimation[a](#jdi13025-note-0001){ref-type="fn"}                             
  ------------------------------------------------ ------------------------- ---------------------------------- ----------- -------------------------------------------------------------------- ------------ ------------ ---------
  Sex                                                                                                                                                                                                                      
  Male                                             549 (84.5%)               1,947 (83.5%)                      0.025       0.568                                                                1.00                      
  Female                                           101 (15.5%)               384 (16.5%)                        1.07        0.79--1.46                                                           0.652                     
  Age (years)                                                                                                                                                                                                              
  Mean (SD)                                        55.0 (6.4)                52.8 (6.9)                         0.327       \<0.001                                                                                        
  40--44                                           65 (10.0%)                390 (16.7%)                        0.199                                                                            1.00                      
  45--49                                           78 (12.0%)                372 (16.0%)                        0.114                                                                            0.70         0.48--1.03   0.072
  50--54                                           116 (17.8%)               519 (22.3%)                        0.111       \<0.001                                                              0.76         0.53--1.09   0.129
  55--59                                           176 (27.1%)               538 (23.1%)                        0.092                                                                            0.53         0.37--0.75   \<0.001
  60--64                                           215 (33.1%)               512 (22.0%)                        0.251                                                                            0.38         0.26--0.55   \<0.001
  Demographic and physical characteristics                                                                                                                                                                                 
  Mean BMI (kg/m^2^)                               26.4 (4.3)                26.3 (4.3)                         0.020       0.657                                                                                          
  ≥25                                              390 (60.0%)               1,374 (58.9%)                      0.021       0.628                                                                1.09         0.88--1.35   0.454
  Biochemical characteristics                                                                                                                                                                                              
  Mean HbA1c at baseline (%)                       7.8 (1.6)                 7.5 (1.4)                          0.170       \<0.001                                                                                        
  6.5--6.9                                         274 (42.2%)               1,219 (52.3%)                      0.204                                                                            1.00                      
  7.0--9.9                                         292 (44.9%)               906 (38.9%)                        0.123       \<0.001                                                              0.53         0.43--0.65   \<0.001
  ≥10.0                                            84 (12.9%)                206 (8.8%)                         0.131                                                                            0.26         0.19--0.36   \<0.001
  Abnormal liver function                          227 (34.9%)               796 (34.1%)                        0.016       0.713                                                                0.97         0.78--1.20   0.752
  Mean AST (U/L)                                   30.1 (19.8)               29.0 (17.5)                        0.059       0.165                                                                                          
  Mean ALT (U/L)                                   40.2 (33.9)               39.2 (28.6)                        0.034       0.419                                                                                          
  Mean GGT (U/L)                                   73.4 (69.5)               69.6 (66.5)                        0.056       0.205                                                                                          
  Comorbidity                                                                                                                                                                                                              
  Hypertension without medication                  138 (21.2%)               712 (30.5%)                        0.214       \<0.001                                                              1.03         0.81--1.31   0.779
  Hypertension with medication                     255 (39.2%)               286 (12.3%)                        0.648       \<0.001                                                              0.21         0.17--0.28   \<0.001
  Mean SBP (mmHg)                                  133.3 (18.2)              133.1 (18.7)                       0.008       0.852                                                                                          
  Mean DBP (mmHg)                                  83.1 (11.6)               82.5 (11.8)                        0.046       0.305                                                                                          
  Hypercholesterolemia without medication          523 (80.5%)               2,163 (92.8%)                      0.368       \<0.001                                                              1.57         0.96--2.59   0.074
  Hypercholesterolemia with medication             102 (15.7%)               93 (4.0%)                          0.400       \<0.001                                                              0.60         0.33--1.08   0.089
  Mean TGs (mg/dL)                                 194.1 (176.3)             196.3 (173.5)                      0.013       0.776                                                                                          
  Mean LDL‐C (mg/dL)                               135.1 (35.2)              140.2 (35.2)                       0.145       0.001                                                                                          
  Lifestyle habits                                                                                                                                                                                                         
  Alcohol consumption Rarely or never              263 (40.5%)               920 (39.5%)                        0.020                                                                            1.00                      
  Occasionally                                     175 (26.9%)               676 (29.0%)                        0.046                                                                            1.10         0.86--1.39   0.452
  Every day, \<20 g/day                            57 (8.8%)                 193 (8.3%)                         0.018       0.764                                                                1.21         0.84--1.75   0.302
  Every day, 20--39 g/day                          103 (15.8%)               340 (14.6%)                        0.035                                                                            1.04         0.77--1.40   0.799
  Every day, ≥40 g/day                             52 (8.0%)                 202 (8.7%)                         0.024                                                                            1.13         0.77--1.64   0.533
  Smoking                                          269 (41.4%)               1,136 (48.7%)                      0.148       0.001                                                                1.23         1.00--1.50   0.049
  Physical activities                              215 (33.1%)               834 (35.8%)                        0.057       0.202                                                                1.15         0.93--1.42   0.197
  Walking faster                                   221 (34.0%)               863 (37.0%)                        0.063       0.157                                                                1.14         0.92--1.41   0.230
  Eating fast                                      272 (41.8%)               965 (41.4%)                        0.009       0.838                                                                1.01         0.83--1.24   0.897
  Eating before sleeping                           315 (48.5%)               1,112 (47.7%)                      0.015       0.733                                                                0.90         0.74--1.10   0.306
  Skipping breakfast                               148 (22.8%)               721 (30.9%)                        0.185       \<0.001                                                              1.36         1.09--1.71   0.007
  Sleeping well                                    340 (52.3%)               1,176 (50.5%)                      0.037       0.402                                                                1.01         0.83--1.23   0.922
  Lifestyle improvement                                                                                                                                                                                                    
  Not planning                                     129 (19.8%)               567 (24.3%)                        0.108       0.043                                                                1.00                      
  Starting in the future (e.g., within 6 months)   292 (44.9%)               1,055 (45.3%)                      0.007       0.78                                                                 0.60--1.00   0.052        
  Starting soon (e.g., within a month)             105 (16.2%)               331 (14.2%)                        0.054       0.68                                                                 0.49--0.94   0.019        
  Already trying                                   124 (19.1%)               378 (16.2%)                        0.075       0.73                                                                 0.53--1.00   0.050        
  Socioeconomic status                                                                                                                                                                                                     
  Mean no. dependents                              1.2 (1.2)                 1.3 (1.3)                          0.103       0.023                                                                                          
  0                                                247 (38.0%)               851 (36.5%)                        0.031                                                                            1.00                      
  1                                                177 (27.2%)               579 (24.8%)                        0.055       0.176                                                                1.24         0.96--1.60   0.098
  ≥2                                               226 (34.8%)               901 (38.7%)                        0.081                                                                            1.22         0.95--1.56   0.114
  Mean standard monthly income (\$)                3,117.5 (1752.4)          3,113.4 (1708.0)                   0.002       0.958                                                                                          
  \<2,000                                          145 (22.3%)               537 (23.0%)                        0.017                                                                            1.00                      
  2,000--2,999                                     205 (31.5%)               700 (30.0%)                        0.033                                                                            0.74         0.56--0.98   0.033
  3,000--3,999                                     163 (25.1%)               595 (25.5%)                        0.010       0.394                                                                0.63         0.46--0.87   0.004
  4,000--4,999                                     65 (10.0%)                282 (12.1%)                        0.067                                                                            0.73         0.50--1.09   0.125
  ≥5,000                                           72 (11.1%)                217 (9.3%)                         0.058                                                                            0.58         0.39--0.86   0.007
  Health examination fiscal year                                                                                                                                                                                           
  2011                                             319 (49.1%)               1,153 (49.5%)                      0.008                                                                                                      
  2012                                             163 (25.1%)               657 (28.2%)                        0.070       0.107                                                                1.10         0.87--1.39   0.427
  2013                                             168 (25.8%)               521 (22.4%)                        0.082                                                                            0.79         0.63--1.01   0.057

Adjusted by all variables in this table and residential secondary tiers of medical care.

ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; CI, confidence interval; DBP, diastolic blood pressure, GGT, gamma‐glutamyltransferase; HbA1c, glycated hemoglobin; LDL‐C, low‐density lipoprotein cholesterol; OR, odds ratio; SBP, systolic blood pressure; SD, standard deviation; TG, triglyceride.
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The associations between patient characteristics and irregular visits are shown on the right in Table [1](#jdi13025-tbl-0001){ref-type="table"}. After adjustment in the logistic regression model, age, higher HbA1c level, hypertension with medication and lifestyle improvements were significantly associated with a decreased probability of irregular physician visits, whereas smoking and skipping breakfast were positively associated with irregular visits. Among the socioeconomic status variables, although we did not observe a significant relationship between the number of dependents and irregular visits, compared with those with a standard monthly income \<\$2,000, those with a higher monthly income had a negative association with irregular visits: \$2,000--2,999: OR 0.74 (95% CI 0.56--0.98), \$3,000--3,999: 0.63 (0.46--0.87) and ≥\$5,000: 0.58 (95% CI 0.39--0.86). The C‐statistic of this propensity score estimation model was 0.750, and the model did not reject the null hypothesis by the Hosmer--Lemeshow test (*P* = 0.515).

As a result of propensity score matching, 580 participants each were assigned to both groups. As shown in Table [2](#jdi13025-tbl-0002){ref-type="table"}, no significant difference between the irregular and regular visit groups in terms of patient characteristics was observed after matching.

###### 

Baseline characteristics of participants by physician visit patterns after propensity score matching

  ---------------------------------------------------------------------------------------------------------------------------------
                                                   Physician visit pattern   Absolute standardized difference   *P‐*value   
  ------------------------------------------------ ------------------------- ---------------------------------- ----------- -------
  Sex                                                                                                                       

  Male                                             492 (84.8%)               494 (85.2%)                        0.010       0.869

  Female                                           88 (15.2%)                86 (14.8%)                                     

  Age (years)                                                                                                               

  Mean (SD)                                        54.7 (6.5)                54.8 (6.7)                         0.014       0.807

  40--44                                           63 (10.9%)                56 (9.7%)                          0.040       

  45--49                                           76 (13.1%)                83 (14.3%)                         0.035       

  50--54                                           105 (18.1%)               99 (17.1%)                         0.027       0.917

  55--59                                           159 (27.4%)               161 (27.8%)                        0.008       

  60--64                                           177 (30.5%)               181 (31.2%)                        0.015       

  Demographic and physical characteristics                                                                                  

  Mean BMI (kg/m^2^)                               26.3 (4.4)                26.3 (4.1)                         0.004       0.948

  ≥25                                              341 (58.8%)               341 (58.8%)                        0.000       1.000

  Biochemical characteristics                                                                                               

  Mean HbA1c at baseline (%)                       7.8 (1.6)                 7.8 (1.7)                          0.005       0.935

  6.5--6.9                                         253 (43.6%)               242 (41.7%)                        0.038       

  7.0--9.9                                         246 (42.4%)               250 (43.1%)                        0.014       0.753

  ≥10.0                                            81 (14.0%)                88 (15.2%)                         0.034       

  Abnormal liver function                          201 (34.7%)               199 (34.3%)                        0.007       0.902

  Mean AST (U/L)                                   29.7 (17.8)               29.8 (20.5)                        0.008       0.898

  Mean ALT (U/L)                                   39.6 (32.8)               38.9 (29.1)                        0.025       0.674

  Mean GGT (U/L)                                   73.7 (71.1)               72.2 (64.9)                        0.022       0.704

  Comorbidity                                                                                                               

  Hypertension without medication                  137 (23.6%)               129 (22.2%)                        0.033       0.577

  Hypertension with medication                     188 (32.4%)               194 (33.4%)                        0.022       0.708

  Mean SBP (mmHg)                                  133.6 (18.6)              135.3 (18.4)                       0.092       0.119

  Mean DBP (mmHg)                                  83.2 (11.8)               83.0 (11.2)                        0.016       0.779

  Hypercholesterolemia without medication          495 (85.3%)               505 (87.1%)                        0.050       0.395

  Hypercholesterolemia with medication             64 (11.0%)                56 (9.7%)                          0.045       0.441

  Mean TGs (mg/dL)                                 195.3 (176.4)             193.8 (173.1)                      0.008       0.886

  Mean LDL‐C (mg/dL)                               136.6 (35.2)              136.9 (35.2)                       0.009       0.885

  Lifestyle habits                                                                                                          

  Alcohol consumption\                             232 (40.0%)               239 (41.2%)                        0.025       
   Rarely or never                                                                                                          

  Occasionally                                     160 (27.6%)               147 (25.3%)                        0.051       

  Every day, \<20 g/day                            51 (8.8%)                 48 (8.3%)                          0.019       0.884

  Every day, 20--39 g/day                          92 (15.9%)                101 (17.4%)                        0.042       

  Every day, ≥40 g/day                             45 (7.8%)                 45 (7.8%)                          0.000       

  Smoking                                          243 (41.9%)               241 (41.6%)                        0.007       0.905

  Physical activities                              204 (35.2%)               198 (34.1%)                        0.022       0.711

  Walking faster                                   204 (35.2%)               200 (34.5%)                        0.014       0.805

  Eating fast                                      235 (40.5%)               242 (41.7%)                        0.025       0.676

  Eating before sleeping                           271 (46.7%)               267 (46.0%)                        0.014       0.814

  Skipping breakfast                               134 (23.1%)               148 (25.5%)                        0.056       0.338

  Sleeping well                                    303 (52.2%)               287 (49.5%)                        0.055       0.348

  Lifestyle improvement                                                                                                     

  Not planning                                     117 (20.2%)               103 (17.8%)                        0.062       0.757

  Starting in the future (e.g., within 6 months)   256 (44.1%)               268 (46.2%)                        0.042       

  Starting soon (e.g., within a month)             94 (16.2%)                94 (16.2%)                         0.000       

  Already trying                                   113 (19.5%)               115 (19.8%)                        0.009       

  Socioeconomic status                                                                                                      

  Mean no. dependents                              1.2 (1.2)                 1.3 (1.3)                          0.049       0.408

  0                                                216 (37.2%)               215 (37.1%)                        0.004       0.855

  1                                                157 (27.1%)               150 (25.9%)                        0.027       

  ≥2                                               207 (35.7%)               215 (37.1%)                        0.029       

  Mean standard monthly income (\$)                3124.8 (1756.1)           3,034.1 (1694.0)                   0.053       0.371

  \<2,000                                          134 (23.1%)               146 (25.2%)                        0.048       

  2,000--2,999                                     174 (30.0%)               178 (30.7%)                        0.015       

  3,000--3,999                                     148 (25.5%)               145 (25.0%)                        0.012       0.770

  4,000--4,999                                     59 (10.2%)                58 (10.0%)                         0.006       

  ≥5,000                                           65 (11.2%)                53 (9.1%)                          0.068       

  Health examination fiscal year                                                                                            

  2011                                             285 (49.1%)               286 (49.3%)                        0.003       0.932

  2012                                             146 (25.2%)               150 (25.9%)                        0.016       

  2013                                             149 (25.7%)               144 (24.8%)                        0.020       
  ---------------------------------------------------------------------------------------------------------------------------------

ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; DBP, diastolic blood pressure; GGT, gamma‐glutamyltransferase; HbA1c, glycated hemoglobin; LDL‐C, low‐density lipoprotein cholesterol; SBP, systolic blood pressure; SD, standard deviation; TG, triglyceride.
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Comparison of Outcomes {#jdi13025-sec-0016}
----------------------

The results of comparison of outcomes are shown on the left in Table [3](#jdi13025-tbl-0003){ref-type="table"}. In the crude analyses before matching, the numbers and proportions of participants in whom the HbA1c level increased to \>0.5, 1.0 and 20% relatively were: 70 (10.8%), 26 (4.0%) and 13 (2.0%) in the irregular visit group, and 616 (26.4%), 343 (14.7%) and 189 (8.1%) in the regular visit group (all *P*‐values \<0.001). After adjusting for sex, age, baseline HbA1c level, oral hypoglycemic agent use, other lifestyle diseases and lifestyle habits, irregular visits were significantly associated with poor glycemic control: OR for HbA1c increase ≥0.5: 2.04 (95% CI 1.53--2.74); ≥1.0: 3.00 (95% CI 1.92--4.66); ≥20% relatively: 3.09 (95% CI 1.68--5.68).

###### 

Comparison of study outcomes by matched and unmatched participants

                                                    Unmatched physician visit pattern   *P*‐value           Matched physician visit pattern                  *P*‐value                              
  ------------------------------------------------- ----------------------------------- ------------------- ------------------------------------------------ ------------------ ------------------- ---------
  Unadjusted                                                                                                                                                                                        
  No. participants                                  650                                 2,331                                                                580                580                 
  Increase in HbA1c ≥0.5, *n* (%)                   70 (10.8%)                          616 (26.4%)         \<0.001[†](#jdi13025-note-0004){ref-type="fn"}   61 (10.5%)         130 (22.4%)         \<0.001
  Odds ratio (95% CI)                               2.98 (2.28--3.93)                   2.46 (1.75--3.48)                                                                                           
  Increase in HbA1c ≥1.0, *n* (%)                   26 (4.0%)                           343 (14.7%)         \<0.001[†](#jdi13025-note-0004){ref-type="fn"}   23 (4.0%)          73 (12.6%)          \<0.001
  Odds ratio (95% CI)                               4.14 (2.74--6.49)                   3.49 (2.12--5.93)                                                                                           
  Relative increase ≥20% from baseline, *n* (%)     13 (2.0%)                           189 (8.1%)          \<0.001[†](#jdi13025-note-0004){ref-type="fn"}   10 (1.7%)          39 (6.7%)           \<0.001
  Odds ratio (95% CI)                               4.32 (2.45--8.33)                   4.11 (1.99--9.31)                                                                                           
  Adjusted[‡](#jdi13025-note-0005){ref-type="fn"}                                                                                                                                                   
  Increase in HbA1c ≥0.5 (%)                        14.3 (11.2--17.5)                   24.9 (23.2--26.6)   \<0.001                                          12.0 (9.1--15.0)   20.1 (16.8--23.4)   0.001
  Odds ratio (95% CI)                               2.04 (1.53--2.74)                   1.90 (1.30--2.77)                                                                                           
  Increase in HbA1c ≥1.0 (%)                        5.3 (3.3--7.4)                      13.9 (12.5--15.2)   \<0.001                                          4.6 (2.7--6.5)     11.2 (8.6--13.8)    \<0.001
  Odds ratio (95% CI)                               3.00 (1.92--4.66)                   2.75 (1.56--4.82)                                                                                           
  Relative increase of ≥20% from baseline (%)       2.7 (1.2--4.1)                      7.6 (6.6--8.7)      \<0.001                                          2.0 (0.7--3.3)     5.9 (4.0--7.9)      0.004
  Odds ratio (95% CI)                               3.09 (1.68--5.68)                   3.18 (1.46--6.92)                                                                                           

Comparison made using the χ^2^‐test.

Adjusted by sex, age, baseline glycated hemoglobin (HbA1c), oral hypoglycemic agent use, other lifestyle diseases and lifestyle habits.

CI, confidence interval.
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After propensity score matching, significant differences in the frequency of poor glycemic control (all *P*‐values \<0.001) were observed. After adjustment for covariates, those in the irregular visit group were more likely to have poor glycemic control; OR for ≥0.5: 1.90 (95% CI 1.30--2.77); ≥1.0: 2.75 (95% CI 1.56--4.82); ≥20% relatively: 3.18 (95% CI 1.46--6.92).

Discussion {#jdi13025-sec-0017}
==========

In the present study, we investigated the relationship between income levels and irregular physician visits, and examined the consequent effects on poor glycemic control. It was found that there were significant differences in the physician visit patterns between different income groups, and that irregular visits were associated with poor glycemic control.

In Japan, universal health coverage has been achieved, and beneficiaries as well as dependents have to pay 30% of their healthcare spending as calculated by a nationally uniform fee schedule, except for preschool children, people aged \>70 years and those receiving public assistance. Therefore, regardless of their income, Japanese people have equitable accessibility to healthcare for the same treatment. Nevertheless, the present results suggest that those with a lower income had impeded access to regular diabetes treatment. Brown *et al*.[5](#jdi13025-bib-0005){ref-type="ref"} stated that there was cumulative evidence on the association between socioeconomic position and access to primary care physicians or specialists, even in countries in which universal health coverage has been achieved, in addition to uninsured people and beneficiaries of managed care plans. In terms of income, a recent study implemented in Norway, by analyzing administrative panel data for general practitioners, reported that patients with a low income receive shorter consultations and fewer medical tests per visit[8](#jdi13025-bib-0008){ref-type="ref"}. Furthermore, a previous study in Taiwan -- where universal health coverage has been achieved -- reported that people exempted from insurance premiums and copayments showed an association not only with the incidence of type 2 diabetes mellitus, but also hospitalization‐diagnosed diabetes mellitus, and were less likely to receive the recommended diabetes checkups[6](#jdi13025-bib-0006){ref-type="ref"}. Although the present study participants were not exempted from copayments or premiums, as the same copayment would be perceived as expensive among populations with relatively lower incomes, those with lower incomes might be less likely to have regular physician visits.

Furthermore, as we used claims data among employees, employment patterns or environments could affect physician visit patterns. For example, Tsuda *et al*.[17](#jdi13025-bib-0017){ref-type="ref"} reported that employees who could comfortably take a day off or time off work, those with a high level of psychological job control and those referred by occupational health professionals were more likely to visit a doctor after worksite screening for diabetes mellitus, whereas those who worked ≥61 h per week were less likely to visit. Therefore, other socioeconomic factors that could influence physician visits -- such as work style, employment or labor condition, or leisure time -- should be investigated concurrently with the recommendation for a physician visit. Further research should focus on showing the relationship between these factors and physician visit patterns.

Beneficiaries with prior lifestyle improvements were less likely to have irregular physician visits. Having an interest in one\'s own health is key to secondary prevention. As diabetes patients tend to be asymptomatic over a long period spent in a hyperglycemic state, it is important to implement health promotion focusing not only on education, but also health literacy in diabetes mellitus among individuals.

We observed higher ORs for poor glycemic control than those previously reported by Heianza *et al*.[3](#jdi13025-bib-0003){ref-type="ref"} In addition to the differences in the characteristics of the study participants, the present results could be generated by our restricted definition of appropriate physician visit, as a previous study simply focused on the initiation and frequency of visits. Therefore, it is useful to monitor not only treatment initiation and frequency, but also treatment patterns including intervals for effective health promotion. As insurers are able to identify beneficiaries with interrupted treatment and those without treatment using the method used in the present study, they might be able to enhance their disease management program by incorporating specific health checkup data into claims data. The objectives of data health plans include the optimization of health expenditure. A previous study analyzing claims data from Japanese health insurance societies reported that individuals who received treatment for \<6 months had a higher risk of microvascular complications and a significantly higher cumulative healthcare expenditure than the adherent group during the second to fifth‐year period and second to sixth‐year period after treatment initiation during 8 years of follow up[18](#jdi13025-bib-0018){ref-type="ref"}. Although we investigated only the short‐term effects of physician visit patterns on glycemic control, further studies should be implemented to show its long‐term effects on diabetes‐related complications and healthcare resource utilization.

There were several limitations to the present study. First, we could not analyze some important socioeconomic factors, such as education levels and employment status. Second, as we used the standard monthly income of individual beneficiaries, and not that of the household, as a proxy variable of income levels, the present result could not reflect the effect of household income levels on physician visit patterns. Furthermore, because our study participants were only beneficiaries of the Fukuoka branch of the Japanese Health Insurance Association who attended specific health checkups, it would be difficult to generalize the results to other populations. However, as this was a large‐scale insurance‐based study including patients who did not visit medical institutions, a strength of the present study was that the propensity score estimation models considered location bias using data on the residential areas of patients.

In conclusion, we clarified that lower‐income beneficiaries were more likely to have irregular visits, and this consequently resulted in poor glycemic control. Although it would be difficult to implement direct interventions to reduce income inequalities, interventions to improve patients' visiting behaviors would be implementable to indirectly reduce health inequalities. Therefore, insurers' strategies that motivate such beneficiaries, especially those in lower‐income groups, to make regular physician visits would be useful for effective disease management.
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